JAZZ (STOCKS)
Jazz Pharmaceuticals, Inc.
$230.590000
+0.030000 (+0.01%)
Prev close: $230.560000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Renée D. Galá
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $14,485.12M
- Employees
- 2,800
- P/E (TTM)
- -12,532.07
- P/B (TTM)
- 3.19
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
15
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$6.34 | $4.66 | +1.6827 | +36.13% |
|
Dec 2025 (Q4)
|
$6.64 | $6.65 | -0.0074 | -0.11% |
|
Sep 2025 (Q3)
|
$8.13 | $6.04 | +2.0923 | +34.65% |
|
Jun 2025 (Q2)
|
$-8.25 | $-7.76 | -0.4929 | -6.35% |
Financial Statements
| Assets | $11.86B |
| Current Assets | $4.58B |
| Cash | $2.87B |
| Inventory | $437.50M |
| Prepaid Expenses | $149.70M |
| Other Current Assets | $1.12B |
| Noncurrent Assets | $7.28B |
| Intangible Assets | $4.20B |
| Other Non-current Assets | $3.07B |
| Liabilities | $7.33B |
| Current Liabilities | $2.25B |
| Accounts Payable | $100.00M |
| Other Current Liabilities | $2.15B |
| Noncurrent Liabilities | $5.08B |
| Long-term Debt | $5.35B |
| Equity | $4.53B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.53B |
| Liabilities And Equity | $11.86B |